Catalyst Wire Dossier Catalyst Wire Dossier

Kauliv

teriparatide · Strides Pharma (Cyprus) Limited
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Kauliv, covering 2024-11-25 to 2026-08-27. Get the full timeline:

Most recent: EMA Authorised: Kauliv (teriparatide) — Strides Pharma (Cyprus) Limited

See pricing